American Society of Hematology

SHERPA: Blue

People

  1. Lowe
    Lowe
  2. Seshan
    Seshan
  3. Baslan
    Baslan
  4. Dogan
    Dogan
  5. Ghione
    Ghione
  6. Horwitz
    Horwitz
  7. Koche
    Koche
  8. Levine
    Levine
  9. Younes
    Younes
  10. Alija
    Alija

Groups

  1. Center for Hematologic Malignancies (10)
  2. Center for Pancreatic Cancer Research (10)
  3. Department of Medicine (8)
  4. Hematologic Malignancies, Division of (8)
  5. Sloan Kettering Institute Postdocs (7)
  6. Executive Committee, Center for Hematologic Malignancies (6)
  7. GSK Faculty (6)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  9. Biostatistics Service (5)
  10. Epidemiology and Biostatistics (5)
Search Within
  1. "Center for Pancreatic Cancer Research"
  2. "2019"
Formats
  1. Meeting Abstract (10)
Groups
  1. Center for Hematologic Malignancies (10)
  2. Center for Pancreatic Cancer Research (10)
  3. Department of Medicine (8)
  4. Hematologic Malignancies, Division of (8)
  5. Sloan Kettering Institute Postdocs (7)
  6. Executive Committee, Center for Hematologic Malignancies (6)

More Groups

People
  1. Scott Lowe (3)
  2. Venkatraman Seshan (3)
  3. Ahmet Dogan (2)
  4. Anas Younes (2)
  5. Paola Ghione (2)
  6. Richard Koche (2)

More People

Years
  1. 2019 (10)
Publications
  1. Blood (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical factors associated with improved survival following allogeneic HSCT after CD19 CAR therapy in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J. H.; Flynn, J.; Gonen, M.; Bernal, Y.; Diamonte, C.; Halton, E.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R. J.
    Blood (2019)

    Fulltext@MSK | Save
  • Plasma cell myeloma residual disease quantitation using a next-generation sequencing-based IGH clonal rearrangement assay with the aid of a "spike-in" clonal sequence
    Meeting Abstract

    Ho, C.; Syed, M.; Yu, W.; Petrova-Drus, K.; Yao, J. J.; Moung, C.; Chang, J.; Benhamida, J.; Vanderbilt, C.; Roshal, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Incidence of delayed seromas and related risk of BIA-ALCL in a cohort of 3521 breast cancer women with textured implants prospectively followed long term
    Meeting Abstract

    Ghione, P.; Cordeiro, P.; Seshan, V.; Galasso, N.; Ganesan, N.; Hu, Q.; Dogan, A.; Horwitz, S. M.
    Blood (2019)

    Fulltext@MSK | Save
  • Central nervous system prophylaxis with high-dose intravenous methotrexate or intrathecal chemotherapy in patients with diffuse large B-cell lymphoma and high-risk of CNS relapse treated in the rituximab era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Seshan, V.; Noy, A.; Horwitz, S. M.; Palomba, M. L.; Matasar, M. J.; Straus, D. J.; Hamlin, P. A.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Stag2 regulates hematopoietic differentiation and self-renewal through alterations in gene expression and topological control
    Meeting Abstract

    Viny, A. D.; Bowman, R. L.; Liu, Y.; Lavallee, V. P.; Eisman, S.; Xiao, W.; Durham, B. H.; Navitski, A.; Park, J.; Braunstein, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Innate immune signaling suppresses acute leukemia by modifying MYC oncogenic activity
    Meeting Abstract

    Muto, T.; Guillamot, M.; Fang, J.; Redondo, L. Z.; Choi, K.; Gong, Y.; Walker, C. S.; Hueneman, K.; Bolanos, L. C.; Barreyro, L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • TP53 action and the consequences of TP53 mutation in acute myeloid leukemia
    Meeting Abstract

    Lowe, S. W.
    Blood (2019)

    Fulltext@MSK | Save
  • Extended mutational profiling by MSK-IMPACT™ identifies mutations predicting thromboembolic risk in patients with solid tumor malignancy
    Meeting Abstract

    Dunbar, A.; Bolton, K.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J. M.; Kelly, D.; Farina, M.; Kishore, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Leukemia cell of origin influences p53 activity and therapeutic sensitivity via an Evi1-dependent mechanism
    Meeting Abstract

    Cai, S. F.; Chu, S.; Goldberg, A. D.; Parvin, S.; Koche, R.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Dual inhibition of MCL1 and BCL2 in lymphoma using tumor targeted nanoparticles
    Meeting Abstract

    Bala, N. B.; Taghizadeh Manzari, M.; Da Silva Ferreira, M.; Asgari, Z.; Hagen, C.; Seshan, V.; de Stanchina, E.; Manova-Todorova, K.; Heller, D.; Younes, A.
    Blood (2019)

    Fulltext@MSK | Save